China's 2026 medical insurance drug talks begin a month early
AI Summary- China's National Healthcare Security Administration began 2026 drug-list negotiations in Beijing on September 5.
- The preliminary formal-review pass rate reached 92%, eight percentage points above last year.
- Negotiations are expected to last four to five days, with companies entering in half-day batches.